<DOC>
	<DOCNO>NCT01339884</DOCNO>
	<brief_summary>The purpose study determine effect two dos resveratrol take 12 week period , frataxin level individual Friedreich ataxia . This study also measure effect resveratrol marker oxidative stress , clinical measure ataxia , cardiac parameter .</brief_summary>
	<brief_title>A Study Resveratrol Treatment Friedreich Ataxia</brief_title>
	<detailed_description>Resveratrol show promise agent treatment Friedreich ataxia due antioxidant property , neuroprotective effect , ability increase frataxin level vitro vivo . This clinical pilot study aim determine effect two dos resveratrol ( 1g/day 5g/day ) take 12 week , frataxin level individual Friedreich ataxia . Additional outcome measure include effect resveratrol marker oxidative stress , clinical measure ataxia , cardiac parameter ( include relative wall thickness leave ventricular mass index ) .</detailed_description>
	<mesh_term>Ataxia</mesh_term>
	<mesh_term>Cerebellar Ataxia</mesh_term>
	<mesh_term>Friedreich Ataxia</mesh_term>
	<mesh_term>Resveratrol</mesh_term>
	<criteria>Adults Friedreich ataxia due homozygosity GAA repeat expansion intron 1 FXN gene Functional stage Ataxia subscale FARS 1 high Women pregnant lactate Active arrythmias significant cardiac insufficiency Use idebenone , Coenzyme Q vitamin E within 30 day prior enrolment Use amiodarone medication may clinically significant drug interaction safely monitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Friedreich ataxia</keyword>
	<keyword>Resveratrol</keyword>
	<keyword>Frataxin</keyword>
	<keyword>Cardiomyopathy</keyword>
	<keyword>Oxidative stress</keyword>
</DOC>